Results 171 to 180 of about 68,419 (263)

Evaluation of safety and immuno-efficacy of a next generation live-attenuated yellow fever vaccine in cynomolgus macaques

open access: hybrid, 2023
Fabienne Piras-Douce   +6 more
openalex   +1 more source

Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine [PDF]

open access: bronze, 2020
Sapna Sharma   +7 more
openalex   +1 more source

Anterograde transneuronal tracing and genetic control with engineered yellow fever vaccine YFV-17D. [PDF]

open access: yesNat Methods, 2021
Li E   +14 more
europepmc   +1 more source

An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures

open access: green, 2015
Renata Carvalho Pereira   +11 more
openalex   +2 more sources

Plant-produced YFE-1T subunit vaccine against Yellow Fever induces humoral response in captive golden-headed lion tamarin (Leontopithecus chrysomelas) [PDF]

open access: bronze, 2019
André Fernandes   +9 more
openalex   +1 more source

Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone [PDF]

open access: gold, 2018
Franck Touret   +5 more
openalex   +1 more source

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases. [PDF]

open access: yesPLoS Negl Trop Dis, 2021
Tonacio AC   +26 more
europepmc   +1 more source

Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism

open access: gold, 2022
Hong-Jiang Wang   +8 more
openalex   +1 more source

A systematic, unbiased mapping of CD8 + and CD4 + T cell epitopes in Yellow Fever vaccinees [PDF]

open access: gold, 2020
Anette Stryhn   +12 more
openalex   +1 more source

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial. [PDF]

open access: yesLancet Infect Dis, 2023
Kimathi D   +25 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy